The US Food & Drug Administration’s top oncology review manager has a lot to say about the agency’s biggest neurological drug approval in decades.
During a 8 June interview with Prevision Policy’s Kate Rawson, Oncology Center of Excellence Director Richard Pazdur couldn’t wait to talk about the “new of the day”: the 7...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?